1. Home
  2. AVA vs SYRE Comparison

AVA vs SYRE Comparison

Compare AVA & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avista Corporation

AVA

Avista Corporation

N/A

Current Price

$39.71

Market Cap

3.3B

Sector

Utilities

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$41.50

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVA
SYRE
Founded
1889
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.6B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
AVA
SYRE
Price
$39.71
$41.50
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$38.00
$55.57
AVG Volume (30 Days)
655.0K
690.4K
Earning Date
05-28-2026
05-19-2026
Dividend Yield
4.94%
N/A
EPS Growth
3.93
N/A
EPS
2.38
N/A
Revenue
$1,964,000,000.00
N/A
Revenue This Year
$0.20
N/A
Revenue Next Year
$4.12
N/A
P/E Ratio
$16.70
N/A
Revenue Growth
1.34
N/A
52 Week Low
$35.50
$10.91
52 Week High
$43.50
$45.76

Technical Indicators

Market Signals
Indicator
AVA
SYRE
Relative Strength Index (RSI) 40.81 60.87
Support Level $36.51 $14.62
Resistance Level $41.93 $45.76
Average True Range (ATR) 0.83 2.38
MACD -0.30 -0.26
Stochastic Oscillator 17.00 56.92

Price Performance

Historical Comparison
AVA
SYRE

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: